Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.

Current Opinion in Lipidology
Yan Liu, Richard E Morton

Abstract

The aim of this study is to highlight recent studies that have advanced our understanding of apolipoprotein F (ApoF) and its role in lipid metabolism. Previous studies showed that ApoF hepatic mRNA levels are suppressed by fat-enriched diets. Recent studies show this downregulation is mediated by agonist-induced binding of liver X receptor (LXR) and PPARalpha to a regulatory element in the ApoF promoter. First-of-kind in-vivo studies show ApoF lowers low-density lipoprotein levels and enhances reverse cholesterol transport in fat-fed hamsters. Diverse studies collectively provide compelling evidence that cholesteryl ester transfer protein (CETP) plays an important role in regulating lipid metabolism. Inhibiting CETP raises HDL cholesterol. However, considering the recent failures of pharmacological inhibitors of CETP in clinical trials, it does not seem likely that global inhibition of CETP will be beneficial. ApoF is a minor apolipoprotein that functions as a natural inhibitor of CETP. However, ApoF is not a general inhibitor of CETP, but rather it preferentially inhibits CETP activity with LDL. Therefore, ApoF tailors CETP activity so that less tissue-derived cholesterol traffics from HDL into the LDL compartment. Lower LDL c...Continue Reading

References

Aug 1, 1991·European Journal of Clinical Investigation·G FranceschiniC R Sirtori
Oct 4, 1984·Biochimica Et Biophysica Acta·Y S Son, D B Zilversmit
Sep 15, 1994·Biochemical and Biophysical Research Communications·J R DayG Wolfbauer
Dec 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·R E Morton, J V Steinbrunner
Sep 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·R L SeipG Schonfeld
Nov 5, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·A P Serdyuk, R E Morton
Oct 13, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·R E MortonE Quintão
May 18, 2004·Journal of Lipid Research·Charles C SchwartzPatricia S Cooper
Mar 3, 2007·The Journal of Clinical Investigation·Tomas VaisarJay W Heinecke
Nov 15, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·William R LagorDaniel J Rader
Dec 10, 2008·Journal of Lipid Research·Daniel J RaderGeorge H Rothblat
Dec 1, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Hung-Yu SunKung-Chia Young
Nov 12, 2013·Biochemical and Biophysical Research Communications·Liangpeng LiYu Jiang
Oct 29, 2014·FEBS Open Bio·Johann GuillemotNabil G Seidah
Mar 8, 2019·Bioscience Reports·Stefan LjunggrenJohanna Lönn
Dec 10, 2019·Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids·Yan LiuRichard E Morton

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.